Analysis of Skin Lesions for Melanoma Presence by Volatile Spectroscopy Techniques
NCT ID: NCT02393001
Last Updated: 2019-07-24
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
50 participants
OBSERVATIONAL
2015-05-31
2017-10-03
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Melanoma Detection by Oblique-Incidence Optical Spectroscopy
NCT00526032
Identification of Olfactory Biomarkers of Skin Cancer From Skin Odor Samples: a Pilot Study
NCT06493786
Optical Spectroscopy for Cutaneous Cancer
NCT02522793
Natural History Study of Moles and Suspicious Melanoma
NCT00288938
Investigate the Diagnostic Value and Possibilities of OCT in Non-Melanoma Skin Cancer.
NCT00390351
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
This research study will inspect cotton and cloth swabs of normal skin and suspicious areas of the skin that are going to be biopsied just before the biopsy. The swabs will be looked at with a very sensitive chemistry lab analyzer to see if the lab analyzer can confirm conventional lab test findings.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_CONTROL
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Dermatology patients
Patients seen in the dermatology clinic with suspicious skin lesion to be biopsied will have 4 skin swabs, 2 of the skin lesion and 2 of an area of unafflicted skin.
Dermatology patients
Cleanse an area of unafflicted (control) skin with a cotton 2 x 2 dampened with saline.
Dermatology patients
Cleanse a suspicious lesion (potential melanoma) with a saline cotton swab.
Dermatology patients
This intervention follows the standard of care for patients with a suspicious skin lesion (potential melanoma) the physician plans to biopsy. The alcohol swab used to prep the site will be stored for testing rather than discarded.
Dermatology patients
Cleanse an area of unafflicted (control) skin with an alcohol swab.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Dermatology patients
Cleanse an area of unafflicted (control) skin with a cotton 2 x 2 dampened with saline.
Dermatology patients
Cleanse a suspicious lesion (potential melanoma) with a saline cotton swab.
Dermatology patients
This intervention follows the standard of care for patients with a suspicious skin lesion (potential melanoma) the physician plans to biopsy. The alcohol swab used to prep the site will be stored for testing rather than discarded.
Dermatology patients
Cleanse an area of unafflicted (control) skin with an alcohol swab.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Seen at the dermatology clinic \& determined to need a skin biopsy of a suspicious lesion
Exclusion Criteria
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University of Florida
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Nikolaus Gravenstein, MD
Role: PRINCIPAL_INVESTIGATOR
The Jerome H. Modell, MD, Professor of Anesthesiology
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
UF Health
Gainesville, Florida, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
IRB201400739
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.